![]() |
Volumn 350, Issue 9, 2004, Pages 860-861
|
Nasal Vaccination, Escherichia coli Enterotoxin, and Bell's Palsy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENYLATE CYCLASE;
ADJUVANT;
BACTERIAL ANTIGEN;
CHLORIDE;
CHOLERA TOXIN;
CYCLIC AMP;
ESCHERICHIA COLI ENTEROTOXIN;
GANGLIOSIDE;
HEMAGGLUTININ;
INACTIVATED VIRUS VACCINE;
INFLUENZA VACCINE;
LIPOSOME;
MEMBRANE ANTIGEN;
SIALIDASE;
VIROSOME VACCINE;
WATER;
ANTIBODY RESPONSE;
BELL PALSY;
CORRELATION ANALYSIS;
DRUG ADMINISTRATION ROUTE;
DRUG APPROVAL;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
DRUG FORMULATION;
ESCHERICHIA COLI;
HUMAN;
IMMUNE RESPONSE;
INFLUENZA;
INFLUENZA VACCINATION;
INFLUENZA VIRUS;
MUCOSAL IMMUNITY;
NEUROTOXICITY;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
RISK ASSESSMENT;
SEASONAL VARIATION;
TOXIN ANALYSIS;
TOXIN STRUCTURE;
ADJUVANTS, PHARMACEUTIC;
ADMINISTRATION, INTRANASAL;
BELL PALSY;
ENTEROTOXINS;
ESCHERICHIA COLI;
HUMANS;
INFLUENZA VACCINES;
VACCINES, INACTIVATED;
|
EID: 1342268107
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMp048006 Document Type: Review |
Times cited : (129)
|
References (0)
|